QUALITY COST FLOWS IN MANUFACTURING COMPANIES
Acta logistica · 31.12.2022 · 09 (04) · 449-456
DOI: 10.22306/al.v9i4.345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta logistica, online erschienen am 31.12.2022. Verfasst von Petr Bris und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Companies have increasingly focused their attention on quality costs. Therefore, raising awareness of this group of expenses is essential. This paper aims to present a survey on the topic of costs of quality management in manufacturing companies in the Czech Republic. This paper opens with a literature review that focuses on the existing cost of quality models and then focuses on empirical research results. Manufacturing companies represent the framework of this research. The research with a total of 159 respondents provides information about the real market situation. The aim was to determine the significance of costs and cost-effectiveness. The study's findings revealed that 73% of organizations quantify their quality costs completely, 21% of companies quantify their costs only partly (external costs), and 6% of companies do not. 36% of surveyed companies (42 companies) that monitor quality costs use some of the recommended models, mainly the PAF model. The research was confirmed by hypothesis 1 that companies that use some type of evidence cost of quality have lower levels of these costs.
Zitieren
APA
Bris, P., Cermakova, M., & Molnar, V. (2022). QUALITY COST FLOWS IN MANUFACTURING COMPANIES. Acta logistica, 09(04), 449-456. https://doi.org/10.22306/al.v9i4.345
Vancouver
Bris P, Cermakova M, Molnar V. QUALITY COST FLOWS IN MANUFACTURING COMPANIES. Acta logistica. 2022;09(04):449-456. doi:10.22306/al.v9i4.345
BibTeX
@article{Bris2022,
author = {Bris, Petr and Cermakova, Marie and Molnar, Vieroslav},
title = {QUALITY COST FLOWS IN MANUFACTURING COMPANIES},
journal = {Acta logistica},
year = {2022},
volume = {09},
number = {04},
pages = {449--456},
doi = {10.22306/al.v9i4.345}
}
EUVIMED